Mackay Shields LLC Decreases Holdings in UnitedHealth Group Inc (NYSE:UNH)
Mackay Shields LLC cut its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.0% during the 4th quarter, HoldingsChannel reports. The fund owned 324,814 shares of the healthcare conglomerate’s stock after selling 6,693 shares during the quarter. UnitedHealth Group makes up 0.7% of Mackay Shields LLC’s investment portfolio, making the stock its 18th biggest position. Mackay Shields LLC’s holdings in UnitedHealth Group were worth $95,489,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of the business. State Street Corp raised its stake in shares of UnitedHealth Group by 1.4% during the fourth quarter. State Street Corp now owns 45,791,556 shares of the healthcare conglomerate’s stock worth $13,461,802,000 after acquiring an additional 614,433 shares in the last quarter. Sanders Capital LLC raised its stake in shares of UnitedHealth Group by 11.6% during the fourth quarter. Sanders Capital LLC now owns 5,178,244 shares of the healthcare conglomerate’s stock worth $1,708,324,000 after acquiring an additional 539,880 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in shares of UnitedHealth Group by 2.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,678,421 shares of the healthcare conglomerate’s stock worth $1,375,363,000 after acquiring an additional 118,843 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of UnitedHealth Group by 0.9% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 4,089,007 shares of the healthcare conglomerate’s stock worth $1,202,086,000 after acquiring an additional 35,598 shares in the last quarter. Finally, Johanson Financial Advisors Inc. grew its holdings in shares of UnitedHealth Group by 28,935.9% in the fourth quarter. Johanson Financial Advisors Inc. now owns 3,384,419 shares of the healthcare conglomerate’s stock worth $11,512,000 after purchasing an additional 3,372,763 shares during the last quarter. 76.41% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have recently issued reports on UNH. Raymond James raised their target price on shares of UnitedHealth Group from $300.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. Evercore ISI began coverage on shares of UnitedHealth Group in a report on Tuesday, December 10th. They issued a “buy” rating and a $285.00 target price on the stock. Morgan Stanley restated a “buy” rating and issued a $312.00 target price (up previously from $294.00) on shares of UnitedHealth Group in a report on Friday, November 22nd. Argus restated a “buy” rating and issued a $340.00 target price on shares of UnitedHealth Group in a report on Thursday, December 19th. Finally, Citigroup raised their target price on shares of UnitedHealth Group from $286.00 to $346.00 and gave the stock a “buy” rating in a report on Thursday, January 16th. Five analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $318.00.
NYSE:UNH traded up $1.04 during trading hours on Friday, hitting $254.96. The company had a trading volume of 9,959,326 shares, compared to its average volume of 4,473,183. The company has a market capitalization of $249.47 billion, a PE ratio of 17.79, a price-to-earnings-growth ratio of 1.25 and a beta of 0.69. The stock has a 50-day moving average price of $290.72 and a 200 day moving average price of $263.28. UnitedHealth Group Inc has a 52 week low of $208.07 and a 52 week high of $306.71. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 earnings per share for the quarter, beating the consensus estimate of $3.77 by $0.13. The business had revenue of $60.90 billion for the quarter, compared to analysts’ expectations of $61.17 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.28 earnings per share. Analysts anticipate that UnitedHealth Group Inc will post 16.47 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 24th. Investors of record on Monday, March 16th will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 1.69%. The ex-dividend date of this dividend is Friday, March 13th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 28.59%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Trading Stocks – What are percentage gainers?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.